Related Experiment Videos
Ocular neovascularization: a valuable model system.
Peter Anthony Campochiaro1, Sean Francis Hackett
1Department of Ophthalmology, The Johns Hopkins University School of Medicine, Maumenee 719, 600 N. Wolfe Street, Baltimore, MD 21287-9277, USA. pcampo@inmi.edu
Oncogene
|October 7, 2003
Summary
Understanding ocular angiogenesis requires studying protein interactions. The eye model reveals vascular endothelial growth factor (VEGF) is crucial, and its inhibition is a key therapy for neovascularization.
Area of Science:
- Ocular biology and molecular medicine
- Neovascularization research
- Ophthalmology
Background:
- Angiogenesis, the formation of new blood vessels, lacks a single formula, involving complex protein interactions that vary with cell type and protein expression.
- The eye's unique vascular beds, situated between avascular tissues, offer a distinct model for studying and quantifying neovascularization.
- Ocular neovascularization research benefits from the eye's isolated compartment, facilitating gene transfer and the study of specific protein roles.
Purpose of the Study:
- To investigate the molecular signals driving ocular angiogenesis using the eye as a model system.
- To compare the roles of various proteins in different vascular beds within the eye.
- To explore therapeutic strategies for both preventing and regressing ocular neovascularization.
Main Methods:
- Utilizing retina-specific and inducible promoter systems to control protein expression in ocular models.
- Employing gene transfer techniques for delivering therapeutic agents like endostatin and angiostatin.
- Quantifying new vessel formation in the eye's well-defined vascular beds.
Main Results:
- Vascular endothelial growth factor (VEGF) signaling is identified as essential for ocular neovascularization, making its interruption a critical therapeutic strategy.
- Regression of new blood vessels is achievable with agents including combretastatin A-4 phosphate, pigment epithelium-derived factor, and angiopoietin-2.
- Gene transfer of endostatin and angiostatin demonstrated efficacy in ocular neovascularization models, contrasting with variable results in tumor studies.
Conclusions:
- Insights from ocular angiogenesis studies can inform broader concepts, including tumor angiogenesis.
- Targeting VEGF signaling is a vital therapeutic approach for ocular neovascularization.
- Novel agents and gene transfer methods show promise for treating ocular neovascularization and offer perspectives for extraocular tissue studies.